RecruitingNCT03422614

Pathophysiology of Inborn Immunodeficiencies

Pathophysiologie Angeborener Immundefekte


Sponsor

University of Zurich

Enrollment

300 participants

Start Date

Mar 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The pathophysiology of primary immunodeficiencies (PID), which encompass a broad range of different diseases with susceptibility to infection and/or a deregulated inflammatory response, is poorly understood. Available treatments are often not specific for a distinct target and might be associated with side effects. To elucidate pathophysiology of different PIDs, stool, urine, blood, tissue biopsies and/or bone marrow will be collected and analysed for anti-microbial activity and inflammatory response. In a second step, targeted treatment for different PIDs might be developed preclinically and ex vivo according to underlying pathophysiology.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Diagnostic Test for people with primary immune deficiency disorder. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDiagnostic Test

Characterisation of cellular and functional phenotype in different PIDs


Locations(1)

University Children's Hospital Zurich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03422614


Related Trials